Neurocrine Biosciences Inc. (NBIX)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 1 |
| Ownership rank: | 866 |
| % of all portfolios: | 0.006% |
| History | Portfolio Manager | Activity | Share change | % change to portfolio ▼ | |
| Q2 2026 | |||||
| ≡ | Dodge & Cox Funds | Add 2.26% | 123,670 | 0.01 | |
| Q1 2026 | |||||
| ≡ | Dodge & Cox Funds | Reduce 0.85% | 47,005 | 0.00 | |
| Q4 2025 | |||||
| ≡ | Dodge & Cox Funds | Reduce 0.87% | 48,576 | 0.00 | |
| Q3 2025 | |||||
| ≡ | Dodge & Cox Funds | Reduce 0.18% | 10,196 | 0.00 | |
| Q2 2025 | |||||
| ≡ | Dodge & Cox Funds | Add 0.58% | 32,190 | 0.00 | |
| Q1 2025 | |||||
| ≡ | Dodge & Cox Funds | Add 83.48% | 2,518,199 | 0.16 | |
| Q4 2024 | |||||
| ≡ | Dodge & Cox Funds | Add 134.23% | 1,728,605 | 0.14 | |
| Q3 2024 | |||||
| ≡ | Dodge & Cox Funds | Add 0.55% | 7,000 | 0.00 | |
| Q2 2024 | |||||
| ≡ | Dodge & Cox Funds | Add 1.23% | 15,576 | 0.00 | |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.